🇺🇸 FDA
Patent

US 11084859

Targeted mutant interferon-gamma and uses thereof

granted A61KA61K38/00A61P

Quick answer

US patent 11084859 (Targeted mutant interferon-gamma and uses thereof) held by Orionis Biosciences, Inc expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Orionis Biosciences, Inc
Grant date
Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K38/00, A61P, A61P31/04, A61P31/10